226 related articles for article (PubMed ID: 26169745)
1. Metabolic signatures differentiate ovarian from colon cancer cell lines.
Halama A; Guerrouahen BS; Pasquier J; Diboun I; Karoly ED; Suhre K; Rafii A
J Transl Med; 2015 Jul; 13():223. PubMed ID: 26169745
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
3. A metabolomic approach to identifying platinum resistance in ovarian cancer.
Poisson LM; Munkarah A; Madi H; Datta I; Hensley-Alford S; Tebbe C; Buekers T; Giri S; Rattan R
J Ovarian Res; 2015 Mar; 8():13. PubMed ID: 25880539
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model.
Jones CM; Monge ME; Kim J; Matzuk MM; Fernández FM
J Proteome Res; 2015 Feb; 14(2):917-27. PubMed ID: 25567202
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells.
Tolstikov V; Nikolayev A; Dong S; Zhao G; Kuo MS
PLoS One; 2014; 9(12):e114019. PubMed ID: 25486521
[TBL] [Abstract][Full Text] [Related]
6. A biochemical comparison of the lung, colonic, brain, renal, and ovarian cancer cell lines using 1H-NMR spectroscopy.
Hu C; Liu Z; Zhao H; Wu L; Lian Q; Ma D; Li JV
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266944
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive polar metabolomics and lipidomics profiling discriminates the transformed from the non-transformed state in colon tissue and cell lines.
Rombouts C; De Spiegeleer M; Van Meulebroek L; Vanhaecke L; De Vos WH
Sci Rep; 2021 Aug; 11(1):17249. PubMed ID: 34446738
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics in cell culture--a strategy to study crucial metabolic pathways in cancer development and the response to treatment.
Halama A
Arch Biochem Biophys; 2014 Dec; 564():100-9. PubMed ID: 25218088
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines.
Willmann L; Schlimpert M; Halbach S; Erbes T; Stickeler E; Kammerer B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():95-104. PubMed ID: 26218769
[TBL] [Abstract][Full Text] [Related]
11. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.
Hirayama A; Kami K; Sugimoto M; Sugawara M; Toki N; Onozuka H; Kinoshita T; Saito N; Ochiai A; Tomita M; Esumi H; Soga T
Cancer Res; 2009 Jun; 69(11):4918-25. PubMed ID: 19458066
[TBL] [Abstract][Full Text] [Related]
12. Nesting of colon and ovarian cancer cells in the endothelial niche is associated with alterations in glycan and lipid metabolism.
Halama A; Guerrouahen BS; Pasquier J; Satheesh NJ; Suhre K; Rafii A
Sci Rep; 2017 Jan; 7():39999. PubMed ID: 28051182
[TBL] [Abstract][Full Text] [Related]
13. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
14. Expanded metabolomics approach to profiling endogenous carbohydrates in the serum of ovarian cancer patients.
Cheng Y; Li L; Zhu B; Liu F; Wang Y; Gu X; Yan C
J Sep Sci; 2016 Jan; 39(2):316-23. PubMed ID: 26549419
[TBL] [Abstract][Full Text] [Related]
15. Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.
Amano Y; Mandai M; Yamaguchi K; Matsumura N; Kharma B; Baba T; Abiko K; Hamanishi J; Yoshioka Y; Konishi I
Oncotarget; 2015 Sep; 6(28):26002-17. PubMed ID: 26318292
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line.
Gao D; Wang Y; Xie W; Yang T; Jiang Y; Guo Y; Guan J; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1014():17-23. PubMed ID: 26859520
[TBL] [Abstract][Full Text] [Related]
17. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
18. Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer.
Chen J; Zhou L; Zhang X; Lu X; Cao R; Xu C; Xu G
Electrophoresis; 2012 Nov; 33(22):3361-9. PubMed ID: 23109122
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
[TBL] [Abstract][Full Text] [Related]
20. NMR metabolic fingerprints of murine melanocyte and melanoma cell lines: application to biomarker discovery.
Santana-Filho AP; Jacomasso T; Riter DS; Barison A; Iacomini M; Winnischofer SM; Sassaki GL
Sci Rep; 2017 Feb; 7():42324. PubMed ID: 28198377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
